[Evaluation of prognostic factors for liposarcoma]

Area of Science:

• Oncology
• Surgical Pathology
• Cancer Research

Background:

• Liposarcoma (LPS) is a complex soft tissue sarcoma with varying subtypes and locations.
• Identifying prognostic factors is crucial for optimizing treatment strategies and improving patient outcomes.

Purpose of the Study:

• To investigate the prognostic factors influencing progression-free survival (PFS) and overall survival (OS) in liposarcoma (LPS) patients.
• To determine the impact of tumor location, histological subtype, and treatment modalities on LPS outcomes.

Main Methods:

• Retrospective analysis of 78 LPS patients treated between July 2009 and March 2017.
• Evaluation of clinical data including tumor characteristics, treatment received, and survival outcomes.
• Univariate and multivariate analyses (Cox regression) to identify independent prognostic factors for PFS and OS.

Main Results:

• Tumor location was identified as an independent prognostic factor for PFS (P<0.05).
• Histological subtype and metastasis were independent prognostic factors for OS (P<0.05).
• Retroperitoneal LPS exhibited higher rates of local recurrence and distant metastasis compared to extremity LPS.
• Postoperative radiotherapy showed a significant improvement in PFS for myxoid LPS patients (34.6 vs. 28.3 months, P<0.05).

Conclusions:

• Tumor location is a critical independent prognostic factor for PFS in LPS.
• Retroperitoneal liposarcoma is associated with a higher risk of relapse and metastasis.
• Overall survival is significantly influenced by pathological subtype and the presence of metastasis.
• Radiotherapy may enhance PFS in patients with myxoid liposarcoma.